Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 23303854)

1.

Functional impairment in progressive supranuclear palsy.

Duff K, Gerstenecker A, Litvan I; investigators and coordinators of the ENGENE-PSP Study Group.

Neurology. 2013 Jan 22;80(4):380-4. doi: 10.1212/WNL.0b013e31827f0859. Epub 2013 Jan 9.

2.

Rate of decline in progressive supranuclear palsy.

Litvan I, Kong M.

Mov Disord. 2014 Apr;29(4):463-8. doi: 10.1002/mds.25843. Epub 2014 Feb 24.

PMID:
24615741
3.

Behavioral abnormalities in progressive supranuclear palsy.

Gerstenecker A, Duff K, Mast B, Litvan I; ENGENE-PSP Study Group.

Psychiatry Res. 2013 Dec 30;210(3):1205-10. doi: 10.1016/j.psychres.2013.08.045. Epub 2013 Sep 12.

4.

Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.

Neely KA, Planetta PJ, Prodoehl J, Corcos DM, Comella CL, Goetz CG, Shannon KL, Vaillancourt DE.

PLoS One. 2013;8(3):e58403. doi: 10.1371/journal.pone.0058403. Epub 2013 Mar 11.

5.

Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.

Giordano A, Tessitore A, Corbo D, Cirillo G, de Micco R, Russo A, Liguori S, Cirillo M, Esposito F, Tedeschi G.

Parkinsonism Relat Disord. 2013 Jun;19(6):590-4. doi: 10.1016/j.parkreldis.2013.02.005. Epub 2013 Mar 7.

PMID:
23477861
6.

Functional disturbance of the locomotor network in progressive supranuclear palsy.

Zwergal A, la Fougère C, Lorenzl S, Rominger A, Xiong G, Deutschenbaur L, Schöberl F, Linn J, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn K.

Neurology. 2013 Feb 12;80(7):634-41. doi: 10.1212/WNL.0b013e318281cc43. Epub 2013 Jan 23.

PMID:
23345641
7.

Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy.

Gawel M, Jamrozik Z, Szmidt-Salkowska E, Slawek J, Gawel D, Rowińska-Marcińska K, Kaminska A.

J Neurol Sci. 2013 Jan 15;324(1-2):136-9. doi: 10.1016/j.jns.2012.10.023. Epub 2012 Nov 10.

PMID:
23146616
8.

Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

Gerstenecker A, Mast B, Duff K, Ferman TJ, Litvan I; ENGENE-PSP Study Group.

Arch Clin Neuropsychol. 2013 Mar;28(2):104-13. doi: 10.1093/arclin/acs098. Epub 2012 Nov 4.

9.

Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia.

Chiu WZ, Papma JM, de Koning I, Donker Kaat L, Seelaar H, Reijs AE, Valkema R, Hasan D, Boon AJ, van Swieten JC.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):910-5. doi: 10.1136/jnnp-2011-302035. Epub 2012 Jun 25.

PMID:
22733085
10.

Direction specific preserved limits of stability in early progressive supranuclear palsy: a dynamic posturographic study.

Ganesan M, Pasha SA, Pal PK, Yadav R, Gupta A.

Gait Posture. 2012 Apr;35(4):625-9. doi: 10.1016/j.gaitpost.2011.12.012. Epub 2012 Jan 4.

PMID:
22225854
11.

Clinical pain and experimental pain sensitivity in progressive supranuclear palsy.

Stamelou M, Dohmann H, Brebermann J, Boura E, Oertel WH, Höglinger G, Möller JC, Mylius V.

Parkinsonism Relat Disord. 2012 Jun;18(5):606-8. doi: 10.1016/j.parkreldis.2011.11.010. Epub 2011 Nov 30.

PMID:
22130148
12.

Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease.

Nomura T, Inoue Y, Takigawa H, Nakashima K.

Parkinsonism Relat Disord. 2012 May;18(4):394-6. doi: 10.1016/j.parkreldis.2011.10.018. Epub 2011 Nov 23.

PMID:
22115673
13.

Instability of syllable repetition in progressive supranuclear palsy.

Skodda S, Grönheit W, Schlegel U.

J Neural Transm. 2012 Apr;119(4):457-62. doi: 10.1007/s00702-011-0737-z. Epub 2011 Nov 8.

PMID:
22065210
14.

Gray matter correlates of behavioral severity in progressive supranuclear palsy.

Josephs KA, Whitwell JL, Eggers SD, Senjem ML, Jack CR Jr.

Mov Disord. 2011 Feb 15;26(3):493-8. doi: 10.1002/mds.23471. Epub 2011 Jan 12.

PMID:
21462261
15.

Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study.

Shirota Y, Hamada M, Hanajima R, Terao Y, Matsumoto H, Ohminami S, Tsuji S, Ugawa Y.

Mov Disord. 2010 Oct 30;25(14):2413-9. doi: 10.1002/mds.23298.

PMID:
20818672
16.

Behavioural symptoms in progressive supranuclear palsy and frontotemporal dementia.

Bak TH, Crawford LM, Berrios G, Hodges JR.

J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):1057-9. doi: 10.1136/jnnp.2008.157974. No abstract available.

PMID:
20798203
17.

Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.

Warnecke T, Oelenberg S, Teismann I, Hamacher C, Lohmann H, Ringelstein EB, Dziewas R.

Mov Disord. 2010 Jul 15;25(9):1239-45. doi: 10.1002/mds.23060.

PMID:
20629130
18.

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS Study Group.

Brain. 2010 Aug;133(Pt 8):2382-93. doi: 10.1093/brain/awq158. Epub 2010 Jun 24.

19.

Acoustical analysis of speech in progressive supranuclear palsy.

Skodda S, Visser W, Schlegel U.

J Voice. 2011 Nov;25(6):725-31. doi: 10.1016/j.jvoice.2010.01.002. Epub 2010 May 8.

PMID:
20457507
20.

Progressive supranuclear palsy: a review of co-existing neurodegeneration.

Keith-Rokosh J, Ang LC.

Can J Neurol Sci. 2008 Nov;35(5):602-8.

PMID:
19235444
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk